Last updated: 2026-09-05 22:08:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
PepGen Inc. (PEPG) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $3.11, with a market capitalization of $220.25M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.21 to $7.80. This page covers its latest market performance, valuation, price trends and company information.
$220.25M | |
$3.14 | |
$20.00 | |
$0.88 | |
$3.18 | |
187.24K | |
-- | |
-- | |
$7.80 | |
$1.21 | |
-- | |
-- |
PepGen Inc. (PEPG) last closed at $3.18 as of 2026-09-04 23:56:00, unchanged from the previous close of $3.18.
During the latest regular trading session, PEPG traded between $0.88 and $20.00, with a volume of 187.24K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, PepGen Inc. (PEPG) moved from $3.04 to $3.11, representing a gain of 2.14% ($0.06).
The stock traded between $3.10 and $3.19 during the period. The latest price is near the lower end of the 7-day range, indicating moderate upward.
The average daily volume was 408.09 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 28.8%
PEPG is currently trading at $3.11, placing it 28.8% of the way from its 52-week low of $1.21 to its 52-week high of $7.80. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed that their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle, and the central nervous system. Its pipeline products are: PGN-EDO51, PGN-EDODM1, and others.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 57 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of PepGen Inc. (PEPG) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.